Filed: 5/15/2026ACC: 0002077247-26-000003
📋 What this filing means
TRAILS EDGE CAPITAL PARTNERS, LP filed this quarterly 13F‑HR report disclosing 26 equity positions with a total reported market value of $436.53M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
26
Positions
$436.53M
Total AUM (reported)
33.27M
Total Shares
Allocation by class
COM$260.01M59.6%
COM SHS$72.46M16.6%
COM NEW$56.42M12.9%
ADS$35.33M8.1%
SHS NEW$6.77M1.6%
CL A NEW$5.54M1.3%
Portfolio Concentration
Top 3$108.56M24.9%
4–10$177.16M40.6%
11–25$148.53M34.0%
Rest$2.27M0.5%
Top 3 weight
24.9%
Top 10 weight
65.5%
Voting Authority Distribution
Total shares with voting rights: 33.27M
Sole
Full voting authority
33.27M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole26
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings26
Rows:
VAXCYTE INC
SOLEShares662.47K
TypeSH
Market value$38.50M
8.82%
Sole
662.47K
Shared
0.00
None
0.00
XENON PHARMACEUTICALS INC
SOLEShares640K
TypeSH
Market value$37.22M
8.53%
Sole
640K
Shared
0.00
None
0.00
DEFINIUM THERAPEUTICS INC
SOLEShares1.74M
TypeSH
Market value$32.85M
7.53%
Sole
1.74M
Shared
0.00
None
0.00
LB PHARMACEUTICALS INC
SOLEShares1.32M
TypeSH
Market value$32.54M
7.45%
Sole
1.32M
Shared
0.00
None
0.00
MIRUM PHARMACEUTICALS INC
SOLEShares333.31K
TypeSH
Market value$30.79M
7.05%
Sole
333.31K
Shared
0.00
None
0.00
NURIX THERAPEUTICS INC
SOLEShares1.74M
TypeSH
Market value$27.02M
6.19%
Sole
1.74M
Shared
0.00
None
0.00
REVOLUTION MEDICINES INC
SOLEShares245K
TypeSH
Market value$23.83M
5.46%
Sole
245K
Shared
0.00
None
0.00
ARCUS BIOSCIENCES INC
SOLEShares1.05M
TypeSH
Market value$22.64M
5.19%
Sole
1.05M
Shared
0.00
None
0.00
IMMUNOCORE HLDGS PLC
SOLEShares682.60K
TypeSH
Market value$20.58M
4.71%
Sole
682.60K
Shared
0.00
None
0.00
CYTOKINETICS INC
SOLEShares300K
TypeSH
Market value$19.77M
4.53%
Sole
300K
Shared
0.00
None
0.00
SYNDAX PHARMACEUTICALS INC
SOLEShares701.82K
TypeSH
Market value$16.39M
3.76%
Sole
701.82K
Shared
0.00
None
0.00
NEUROGENE INC
SOLEShares782.79K
TypeSH
Market value$15.78M
3.62%
Sole
782.79K
Shared
0.00
None
0.00
INVENTIVA SA
SOLEShares2.66M
TypeSH
Market value$14.75M
3.38%
Sole
2.66M
Shared
0.00
None
0.00
INHIBIKASE THERAPEUTICS INC
SOLEShares8.06M
TypeSH
Market value$13.54M
3.10%
Sole
8.06M
Shared
0.00
None
0.00
4D MOLECULAR THERAPEUTICS IN
SOLEShares1.30M
TypeSH
Market value$12.13M
2.78%
Sole
1.30M
Shared
0.00
None
0.00
X4 PHARMACEUTICALS INC
SOLEShares2.57M
TypeSH
Market value$10.62M
2.43%
Sole
2.57M
Shared
0.00
None
0.00
IMMUNOVANT INC
SOLEShares414.05K
TypeSH
Market value$10.29M
2.36%
Sole
414.05K
Shared
0.00
None
0.00
DESIGN THERAPEUTICS INC
SOLEShares852.01K
TypeSH
Market value$9.07M
2.08%
Sole
852.01K
Shared
0.00
None
0.00
CAMP4 THERAPEUTICS CORP
SOLEShares1.94M
TypeSH
Market value$8.55M
1.96%
Sole
1.94M
Shared
0.00
None
0.00
MINERVA NEUROSCIENCES INC
SOLEShares1.42M
TypeSH
Market value$8.55M
1.96%
Sole
1.42M
Shared
0.00
None
0.00
PROMIS NEUROSCIENCES INC
SOLEShares557.10K
TypeSH
Market value$7.08M
1.62%
Sole
557.10K
Shared
0.00
None
0.00
SOL-GEL TECHNOLOGIES LTD
SOLEShares85.50K
TypeSH
Market value$6.77M
1.55%
Sole
85.50K
Shared
0.00
None
0.00
CENTURY THERAPEUTICS INC
SOLEShares2.45M
TypeSH
Market value$5.54M
1.27%
Sole
2.45M
Shared
0.00
None
0.00
VTV THERAPEUTICS INC
SOLEShares139.58K
TypeSH
Market value$5.54M
1.27%
Sole
139.58K
Shared
0.00
None
0.00
SENSEI BIOTHERAPEUTICS INC
SOLEShares125K
TypeSH
Market value$3.94M
0.90%
Sole
125K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
VAXCYTE INCSOLE | COM | 662.47K | SH | $38.50M 8.82% | 662.47K | 0.00 | 0.00 |
XENON PHARMACEUTICALS INCSOLE | COM | 640K | SH | $37.22M 8.53% | 640K | 0.00 | 0.00 |
DEFINIUM THERAPEUTICS INCSOLE | COM SHS | 1.74M | SH | $32.85M 7.53% | 1.74M | 0.00 | 0.00 |
LB PHARMACEUTICALS INCSOLE | COM SHS | 1.32M | SH | $32.54M 7.45% | 1.32M | 0.00 | 0.00 |
MIRUM PHARMACEUTICALS INCSOLE | COM | 333.31K | SH | $30.79M 7.05% | 333.31K | 0.00 | 0.00 |
NURIX THERAPEUTICS INCSOLE | COM | 1.74M | SH | $27.02M 6.19% | 1.74M | 0.00 | 0.00 |
REVOLUTION MEDICINES INCSOLE | COM | 245K | SH | $23.83M 5.46% | 245K | 0.00 | 0.00 |
ARCUS BIOSCIENCES INCSOLE | COM | 1.05M | SH | $22.64M 5.19% | 1.05M | 0.00 | 0.00 |
IMMUNOCORE HLDGS PLCSOLE | ADS | 682.60K | SH | $20.58M 4.71% | 682.60K | 0.00 | 0.00 |
CYTOKINETICS INCSOLE | COM NEW | 300K | SH | $19.77M 4.53% | 300K | 0.00 | 0.00 |
SYNDAX PHARMACEUTICALS INCSOLE | COM | 701.82K | SH | $16.39M 3.76% | 701.82K | 0.00 | 0.00 |
NEUROGENE INCSOLE | COM | 782.79K | SH | $15.78M 3.62% | 782.79K | 0.00 | 0.00 |
INVENTIVA SASOLE | ADS | 2.66M | SH | $14.75M 3.38% | 2.66M | 0.00 | 0.00 |
INHIBIKASE THERAPEUTICS INCSOLE | COM NEW | 8.06M | SH | $13.54M 3.10% | 8.06M | 0.00 | 0.00 |
4D MOLECULAR THERAPEUTICS INSOLE | COM | 1.30M | SH | $12.13M 2.78% | 1.30M | 0.00 | 0.00 |
X4 PHARMACEUTICALS INCSOLE | COM NEW | 2.57M | SH | $10.62M 2.43% | 2.57M | 0.00 | 0.00 |
IMMUNOVANT INCSOLE | COM | 414.05K | SH | $10.29M 2.36% | 414.05K | 0.00 | 0.00 |
DESIGN THERAPEUTICS INCSOLE | COM | 852.01K | SH | $9.07M 2.08% | 852.01K | 0.00 | 0.00 |
CAMP4 THERAPEUTICS CORPSOLE | COM | 1.94M | SH | $8.55M 1.96% | 1.94M | 0.00 | 0.00 |
MINERVA NEUROSCIENCES INCSOLE | COM NEW | 1.42M | SH | $8.55M 1.96% | 1.42M | 0.00 | 0.00 |
PROMIS NEUROSCIENCES INCSOLE | COM SHS | 557.10K | SH | $7.08M 1.62% | 557.10K | 0.00 | 0.00 |
SOL-GEL TECHNOLOGIES LTDSOLE | SHS NEW | 85.50K | SH | $6.77M 1.55% | 85.50K | 0.00 | 0.00 |
CENTURY THERAPEUTICS INCSOLE | COM | 2.45M | SH | $5.54M 1.27% | 2.45M | 0.00 | 0.00 |
VTV THERAPEUTICS INCSOLE | CL A NEW | 139.58K | SH | $5.54M 1.27% | 139.58K | 0.00 | 0.00 |
SENSEI BIOTHERAPEUTICS INCSOLE | COM NEW | 125K | SH | $3.94M 0.90% | 125K | 0.00 | 0.00 |
Page 1 of 2